Researchers at Case Western Reserve University and University Hospitals have identified an enzyme that blocks insulin produced in the body—a discovery that could provide a new target to treat diabetes.

Easee, a digital healthcare speicalist, has achieved the CE mark Class II under the new European Union Medical Device Regulation (Regulation (EU) 2017/745) (EU-MDR) which the company says is the world’s first and only CE certified online eye exam with refraction capabilities.

Bioliberty, a medtech start-up which has created a soft robotic glove to help rehabilitate stroke patients, has received almost half a million pounds of new funding to accelerate its product to market.

SiteRite™ 9 Ultrasound System Delivers Enhanced Image Quality and Vessel Assessment Tools to Aid in First Attempt IV Insertion Success

The XO Cath microcatheter is designed to deliver new levels of trackability, torque response, and embolic compatibility for improved treatment delivery.

The clearance positions the company to offer an alternative to continuous positive airway pressure devices and neurostimulation implants.

MIT and MGH researchers design a local, gel-based drug-delivery platform that may provoke a system-wide immune response to metastatic tumors.

Researchers from the University of Birmingham have designed and developed a novel diagnostic device to detect traumatic brain injury (TBI) by shining a safe laser into the eye.